Revolutionary new treatment regimens for multidrug-resistant tuberculosis

Lancet Infect Dis. 2019 Mar;19(3):233-234. doi: 10.1016/S1473-3099(19)30060-X.
No abstract available

MeSH terms

  • Administration, Oral
  • Antitubercular Agents / administration & dosage*
  • Drug Therapy, Combination / methods*
  • Guidelines as Topic
  • Humans
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • World Health Organization

Substances

  • Antitubercular Agents